BioSpace News Archive

Corvus Pharmaceuticals, Inc. announced updated results from its Phase 1/1b clinical trial of CPI-818, the Company’s ITK-inhibitor, which were presented in an oral presentation at the 12th Annual T-Cell Lymphoma Forum in La Jolla, California, taking place January 30 to February 1, 2020.

WASHINGTON , Feb. 1, 2020 /PRNewswire/ -- The American Pharmacists Association (APhA) announced today that Scott J. Knoer , MS, PharmD, FASHP, has been named the 13 th Chief Executive Officer/Executive Vice President of APhA. Dr. Knoer is the Chief Pharmacy Officer of the Cleveland Clinic, overseeing nearly 1,600 pharmacy FTEs at the